The experimental coronavirus treatment Trump received just got emergency authorization from the FDA
- The US Food and Drug Administration will allow for the emergency use of
Regeneron's COVID-19antibody treatment.
- The antibody treatment was one of the drugs given to President Donald
Trumpafter he was admitted to the hospital with coronavirusin early October.
- Regeneron said it will have enough of the treatment for 80,000 patients by the end of November.
The Food and Drug Administration has allowed for the emergency use of Regeneron's COVID-19 antibody treatment, a step that will make it more widely available to patients.
FDA granted an emergency authorization for the drug, called REGN-COV2, to be used in people with the coronavirus who are at high risk of developing a severe case of the disease, but not for people who are hospitalized or who need oxygen. REGN-COV2 was one of the treatments
"They gave me Regeneron — other things, too — but I think this was the key," he said, adding that he "felt good immediately" after the receiving the antibody combination.The drug company, which started clinical trials on June 11, said that preliminary results from a trial reveal that its antibody treatment could reduce the severity of the virus in non-hospitalized patients with COVID-19. Read more: Trump just received Regeneron's experimental COVID-19 treatment. Here's the inside story of the biotech and its 2 billionaire founders.
- K'taka health minister defends Covaxin, says it's safe
- Expert panel recommends Phase 1 trial of nasal Covid-19 vaccine (IANS Exclusive, Lead)
- Bombay High Court permits Sebamed ads targeting Dove with no changes and asks to put an end on Lux’s comparison with Rin
- Vaccine hesitancy among healthcare workers must end: Govt
- Software firm Magenic is the third acquisition of Cognizant in January this year